Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.35 | 39,620 | 93.11 k | 39,620 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | Yes | No | 1.54 | 30,000 | 46.20 k | 0 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 1.26 | 6,667 | 8.40 k | 6,667 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | Yes | No | 3.61 | 6,667 | 24.07 k | 0 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 1.26 | 6,667 | 8.40 k | 6,667 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | Yes | No | 4.86 | 6,667 | 32.40 k | 0 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | Yes | No | 17.52 | 3,780 | 66.23 k | 0 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 1,138 | 1.43 k | 1,138 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 60 | 1,138 | 68.28 k | 0 |
21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | Yes | No | 33.43 | 21,854 | 730.58 k | 0 |